Luca Signore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luca Signore has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Cosimo Distante
ISASI, Consiglio Nazionale delle Ricerche
1 shared publication - Francesco Corcione
Clinica Mediterranea, 80122 Naples, Italy
1 shared publication - Giulio Benincasa
Department of Clinical Pathology and Molecular Biology, Pineta Grande Hospital, 81030 Castel Volturno, Italy
1 shared publication - Marco Leo
Institute of Applied Sciences and Intelligent Systems, National Research Council of Italy, 73100 Lecce, Italy
1 shared publication - Mikko O. Laukkanen
CNR-IEOS
1 shared publication - Pierluigi Carcagnì
Institute of Applied Sciences and Intelligent Systems, National Research Council of Italy (CNR), 73100 Lecce, Italy
1 shared publication
Latest Publications
- Open Access
Convolutional Neural Networks in the Diagnosis of Colon Adenocarcinoma
Colorectal cancer is one of the most lethal cancers because of late diagnosis and challenges in the selection of therapy options. The histopathological diagnosis of colon adenocarcinoma is hindered by poor reproducibility and a lack of standard examination protocols required for appropriate treatment decisions. In the current study, using state-of-the-art approaches on benchmark datasets, we analyzed different architectures and ensembling strategies to develop the most efficient network combinations to improve binary and ternary classification. We propose an innovative two-stage pipeline approach to diagnose colon adenocarcinoma grading from histological images in a similar manner to a pathologist. The glandular regions were first segmented by a transformer architecture with subsequent classification using a convolutional neural network (CNN) ensemble, which markedly improved the learning efficiency and shortened the learning time. Moreover, we prepared and published a dataset for clinical validation of the developed artificial neural network, which suggested the discovery of novel histological phenotypic alterations in adenocarcinoma sections that could have prognostic value. Therefore, AI could markedly improve the reproducibility, efficiency, and accuracy of colon cancer diagnosis, which are required for precision medicine to personalize the treatment of cancer patients.
Open AccessConvolutional Neural Networks in the Diagnosis of Colon Adenocarcinoma
Colorectal cancer is one of the most lethal cancers because of late diagnosis and challenges in the selection of therapy options. The histopathological diagnosis of colon adenocarcinoma is hindered by poor reproducibility and a lack of standard examination protocols required for appropriate treatment decisions. In the current study, using state-of-the-art approaches on benchmark datasets, we analyzed different architectures and ensembling strategies to develop the most efficient network combinations to improve binary and ternary classification. We propose an innovative two-stage pipeline approach to diagnose colon adenocarcinoma grading from histological images in a similar manner to a pathologist. The glandular regions were first segmented by a transformer architecture with subsequent classification using a convolutional neural network (CNN) ensemble, which markedly improved the learning efficiency and shortened the learning time. Moreover, we prepared and published a dataset for clinical validation of the developed artificial neural network, which suggested the discovery of novel histological phenotypic alterations in adenocarcinoma sections that could have prognostic value. Therefore, AI could markedly improve the reproducibility, efficiency, and accuracy of colon cancer diagnosis, which are required for precision medicine to personalize the treatment of cancer patients.